MelaB3 serum and glycolic acid peel for skin dark spots
Part of Skin clinical trials.
This trial tests if adding MelaB3 serum to a 35% glycolic acid peel works better than the peel alone for treating dark spots caused by melasma, acne scars, or sun damage. It may be a good option if you have mild to moderate dark spots and are willing to avoid sun exposure and other skin-lightening products.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 30 and 70 years old.
- You have mild to moderate dark spots from melasma, acne scars, or sun damage.
- You are willing to use sun protection and avoid other skin-lightening or irritating products during the study.
- You are not pregnant, breastfeeding, or planning pregnancy.
- You do not have active acne flare-ups or other skin conditions like psoriasis, eczema, or rosacea on your face.
- You have not had facial skin treatments (like laser, deep peels, or fillers) in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if adding a special serum to laser treatment can better treat dark spots from acne and melasma in women with medium to dark skin tones. The serum contains ingredients that may help lighten spots and improve skin tone.
This trial tests a skincare formula for treating three types of dark spots on the face: melasma, acne marks, and age spots. It aims to see if the product is effective and gentle after 3 months of daily use.
This trial tests a treatment called Secretome TGF Beta 3 for women with melasma. It aims to see if this treatment can improve dark patches on the skin.
This study tests a new cream for facial dark spots caused by sun damage, melasma, or acne. It aims to see if the cream is safe and effective over three months.
This trial tests two different triple-combination creams for melasma in women with skin types IV or V. Both creams contain a bleaching agent and a retinoid, but one uses a different steroid. The goal is to see which is safer and works better.
This trial tests a daily routine of facial products to see if they can reduce dark patches (melasma) on your face. It is for people who have had melasma for at least a year and have not used certain creams like retinoids or hydroquinone recently.
Hear when a new Hyperpigmentation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.